Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125250521 | 12525052 | 1 | I | 20151220 | 20160627 | 20160704 | 20160704 | EXP | FR-PFIZER INC-2016319362 | PFIZER | 46.00 | YR | F | Y | 0.00000 | 20160704 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125250521 | 12525052 | 1 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 24 G, SINGLE | Y | 0 | 24 | G | |||||||
125250521 | 12525052 | 2 | PS | XANAX | ALPRAZOLAM | 1 | Oral | 60 DF OF 0.25 MG, SINGLE | Y | 18276 | 15 | MG | TABLET | ||||||
125250521 | 12525052 | 3 | C | ANEXATE | FLUMAZENIL | 1 | UNK | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125250521 | 12525052 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125250521 | 12525052 | Acute hepatic failure | |
125250521 | 12525052 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125250521 | 12525052 | 1 | 20151220 | 20151220 | 0 | |
125250521 | 12525052 | 2 | 20151220 | 20151220 | 0 | |
125250521 | 12525052 | 3 | 20151220 | 20151220 | 0 |